BBOX1-AS1 Accelerates Nasopharyngeal Carcinoma Progression by Sponging miR-3940-3p and Enhancing KPNA2 Upregulation

References

• Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet (London, England). 2019;394(10192):64–80. doi:10.1016/s0140-6736(19)30956-0
   PubMed Web of Science ®Google Scholar
• Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet (London, England). 2016;387(10022):1012–1024. doi:10.1016/s0140-6736(15)00055-0
   PubMed Web of Science ®Google Scholar
• Lee HM, Okuda KS, González FE, Patel V. Current perspectives on nasopharyngeal carcinoma. Adv Exp Med Biol. 2019;1164:11–34. doi:10.1007/978-3-030-22254-3_231576537
   PubMed Web of Science ®Google Scholar
• Lee AWM, Ng WT, Chan JYW, et al. Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev. 2019;79:101890. doi:10.1016/j.ctrv.2019.10189031470314
   PubMed Web of Science ®Google Scholar
• Liu D, Xu B, Chen S, et al. Long non-coding RNAs and prostate cancer. J Nanosci Nanotechnol. 2013;13(5):3186–3194. doi:10.1166/jnn.2013.687023858830
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhang X, Gao W, Hu H, Wang X, Hao D. lncRNA/circRNA‑miRNA‑mRNA ceRNA network in lumbar intervertebral disc degeneration. Mol Med Rep. 2019;20(4):3160–3174. doi:10.3892/mmr.2019.1056931432173
   PubMed Web of Science ®Google Scholar
• Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med. 2018;22(12):5768–5775. doi:10.1111/jcmm.1386630188595
   PubMed Web of Science ®Google Scholar
• Fan CN, Ma L, Liu N. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. J Transl Med. 2018;16(1):264. doi:10.1186/s12967-018-1640-230261893
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen W, Lian J, et al. The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α. Cell Death Differ. 2020;27(2):695–710. doi:10.1038/s41418-019-0381-y31320749
   PubMed Web of Science ®Google Scholar
• Zheng ZQ, Li ZX, Zhou GQ, et al. Long noncoding RNA fam225a promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as ceRNA to sponge miR-590-3p/miR-1275 and upregulate ITGB3. Cancer Res. 2019;79(18):4612–4626. doi:10.1158/0008-5472.Can-19-079931331909
   PubMed Web of Science ®Google Scholar
• Xu W, Sun X, Zang C, Jiang Y. lncRNA SNHG7 promotes tumorigenesis of nasopharyngeal carcinoma via epithelial-to-mesenchymal transition. Oncol Lett. 2020;20(4):88. doi:10.3892/ol.2020.1194932863921
   PubMed Web of Science ®Google Scholar
• Liu D, Wang Y, Zhao Y, Gu X. LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179/HMGB3 axis. BMC Cancer. 2020;20(1):178. doi:10.1186/s12885-020-6662-532131767
   PubMed Web of Science ®Google Scholar
• Xu J, Yang B, Wang L, et al. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression. Cell Prolif. 2020;53(7):e12823. doi:10.1111/cpr.1282332515533
   PubMed Web of Science ®Google Scholar
• Yang Y, Yu Q, Li B, Guan R, Huang C, Yang X. BBOX1-AS1 accelerates gastric cancer proliferation by sponging miR-3940-3p to upregulate BIRC5 expression. Dig Dis Sci. 2021;66(4):1054–1062. doi:10.1007/s10620-020-06308-032394331
   PubMed Web of Science ®Google Scholar
• Liu J, Zhu J, Xiao Z, Wang X, Luo J. BBOX1-AS1 contributes to colorectal cancer progression by sponging hsa-miR-361-3p and targeting SH2B1. FEBS Open Bio. 2020. doi:10.1002/2211-5463.12802
   Web of Science ®Google Scholar
• Yao H, Chen R, Yang Y, Jiang J. LncRNA BBOX1-AS1 aggravates the development of ovarian cancer by sequestering miR-361-3p to augment PODXL expression. Reprod Sci (Thousand Oaks, Calif). 2021;28(3):736–744. doi:10.1007/s43032-020-00366-5
   PubMed Web of Science ®Google Scholar
• Nagy Á, Lánczky A, Menyhárt O, Győrffy B. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 2018;8(1):9227. doi:10.1038/s41598-018-27521-y29907753
   PubMed Web of Science ®Google Scholar
• Ma A, Tang M, Zhang L, et al. USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis. Oncogene. 2019;38(13):2405–2419. doi:10.1038/s41388-018-0590-830531833
   PubMed Web of Science ®Google Scholar
• Xiang S, Wang Z, Ye Y, et al. E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer. Oncogene. 2019;38(8):1269–1281. doi:10.1038/s41388-018-0494-730254209
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–5667. doi:10.1038/onc.2017.18428604750
   PubMed Web of Science ®Google Scholar
• Yao L, Wang T, Wang X. LncRNA FOXP4-AS1 serves as a biomarker for nasopharyngeal carcinoma diagnosis and prognosis. 3 Biotech. 2021;11(1):25. doi:10.1007/s13205-020-02593-8
   PubMedGoogle Scholar
• Shi ZL, Zhou GQ, Guo J, et al. Identification of a prognostic colorectal cancer model including LncRNA FOXP4-AS1 and LncRNA BBOX1-AS1 based on bioinformatics analysis. Cancer Biother Radiopharm. 2021. doi:10.1089/cbr.2020.4242
   Web of Science ®Google Scholar
• Han Y, Wang X. The emerging roles of KPNA2 in cancer. Life Sci. 2020;241:117140. doi:10.1016/j.lfs.2019.11714031812670
   PubMed Web of Science ®Google Scholar
• Li J, Liu Q, Liu Z, et al. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc. J Exp Clin Cancer Res. 2018;37(1):194. doi:10.1186/s13046-018-0861-930115078
   PubMed Web of Science ®Google Scholar
• Wang P, Zhao Y, Liu K, et al. Wip1 cooperates with KPNA2 to modulate the cell proliferation and migration of colorectal cancer via a p53-dependent manner. J Cell Biochem. 2019;120(9):15709–15718. doi:10.1002/jcb.2884031127650
   PubMed Web of Science ®Google Scholar